Tetavax, suspenzija za injekciju u napunjenoj štrcaljki, cjepivo protiv tetanusa, adsorbirano
Name | Tetavax, suspenzija za injekciju u napunjenoj štrcaljki, cjepivo protiv tetanusa, adsorbirano |
---|---|
Marketing Authorisation Number | HR-H-943015948 |
Active Substance | toksoid tetanusa |
Composition | jedna doza (0,5 ml) sadrži: Toksoid tetanusa ≥ 40 IU adsorbiran na aluminijev hidroksid, hidrirani 0,6 mg Al |
Pharmaceutical Form | suspenzija za injekciju u napunjenoj štrcaljki |
Manufacturer | Sanofi-Aventis Zrt., Budimpešta, Mađarska Sanofi Pasteur, Lyon, Francuska |
Marketing Authorisation Holder | Sanofi Pasteur, 14 Espace Henry Vallee, Lyon, Francuska |
Marketing Authorisation Date | 20.09.2019 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/17-02/638 |
Registration Number | 381-12-01/30-19-10 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | J07AM01 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |